Vitamin D2 is much less effective than vitamin D3 in humans

Lauka A G Armas, Bruce W. Hollis, Robert P. Heaney

Research output: Contribution to journalArticle

783 Citations (Scopus)

Abstract

Vitamins D2 and D3 are generally considered to be equivalent in humans. Nevertheless, physicians commonly report equivocal responses to seemingly large doses of the only high-dose calciferol (vitamin D2) available in the U.S. market. The relative potencies of vitamins D2 and D3 were evaluated by administering single doses of 50,000 IU of the respective calciferols to 20 healthy male volunteers, following the time course of serum vitamin D and 25-hydroxyvitamin D (25OHD) over a period of 28 d and measuring the area under the curve of the rise in 25OHD above baseline. The two calciferols produced similar rises in serum concentration of the administered vitamin, indicating equivalent absorption. Both produced similar initial rises in serum 25OHD over the first 3 d, but 25OHD continued to rise in the D3-treated subjects, peaking at 14 d, whereas serum 25OHD fell rapidly in the D2-treated subjects and was not different from baseline at 14 d. Area under the curve (AUC) to d 28 was 60.2 ng·d/ml (150.5 nmol·d/liter) for vitamin D2 and 204.7 (511.8) for vitamin D3 (P <0.002). Calculated AUC indicated an even greater differential, with the relative potencies for D 3:D2 being 9.5:1. Vitamin D2 potency is less than one third that of vitamin D3. Physicians resorting to use of vitamin D2 should be aware of its markedly lower potency and shorter duration of action relative to vitamin D3.

Original languageEnglish
Pages (from-to)5387-5391
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number11
DOIs
StatePublished - Nov 2004

Fingerprint

Ergocalciferols
Cholecalciferol
Area Under Curve
Serum
Physicians
Vitamin D
Vitamins
Healthy Volunteers

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Vitamin D2 is much less effective than vitamin D3 in humans. / Armas, Lauka A G; Hollis, Bruce W.; Heaney, Robert P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 11, 11.2004, p. 5387-5391.

Research output: Contribution to journalArticle

Armas, Lauka A G ; Hollis, Bruce W. ; Heaney, Robert P. / Vitamin D2 is much less effective than vitamin D3 in humans. In: Journal of Clinical Endocrinology and Metabolism. 2004 ; Vol. 89, No. 11. pp. 5387-5391.
@article{640d81c770df451fae7f84ff17da2440,
title = "Vitamin D2 is much less effective than vitamin D3 in humans",
abstract = "Vitamins D2 and D3 are generally considered to be equivalent in humans. Nevertheless, physicians commonly report equivocal responses to seemingly large doses of the only high-dose calciferol (vitamin D2) available in the U.S. market. The relative potencies of vitamins D2 and D3 were evaluated by administering single doses of 50,000 IU of the respective calciferols to 20 healthy male volunteers, following the time course of serum vitamin D and 25-hydroxyvitamin D (25OHD) over a period of 28 d and measuring the area under the curve of the rise in 25OHD above baseline. The two calciferols produced similar rises in serum concentration of the administered vitamin, indicating equivalent absorption. Both produced similar initial rises in serum 25OHD over the first 3 d, but 25OHD continued to rise in the D3-treated subjects, peaking at 14 d, whereas serum 25OHD fell rapidly in the D2-treated subjects and was not different from baseline at 14 d. Area under the curve (AUC) to d 28 was 60.2 ng·d/ml (150.5 nmol·d/liter) for vitamin D2 and 204.7 (511.8) for vitamin D3 (P <0.002). Calculated AUC∞ indicated an even greater differential, with the relative potencies for D 3:D2 being 9.5:1. Vitamin D2 potency is less than one third that of vitamin D3. Physicians resorting to use of vitamin D2 should be aware of its markedly lower potency and shorter duration of action relative to vitamin D3.",
author = "Armas, {Lauka A G} and Hollis, {Bruce W.} and Heaney, {Robert P.}",
year = "2004",
month = "11",
doi = "10.1210/jc.2004-0360",
language = "English",
volume = "89",
pages = "5387--5391",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Vitamin D2 is much less effective than vitamin D3 in humans

AU - Armas, Lauka A G

AU - Hollis, Bruce W.

AU - Heaney, Robert P.

PY - 2004/11

Y1 - 2004/11

N2 - Vitamins D2 and D3 are generally considered to be equivalent in humans. Nevertheless, physicians commonly report equivocal responses to seemingly large doses of the only high-dose calciferol (vitamin D2) available in the U.S. market. The relative potencies of vitamins D2 and D3 were evaluated by administering single doses of 50,000 IU of the respective calciferols to 20 healthy male volunteers, following the time course of serum vitamin D and 25-hydroxyvitamin D (25OHD) over a period of 28 d and measuring the area under the curve of the rise in 25OHD above baseline. The two calciferols produced similar rises in serum concentration of the administered vitamin, indicating equivalent absorption. Both produced similar initial rises in serum 25OHD over the first 3 d, but 25OHD continued to rise in the D3-treated subjects, peaking at 14 d, whereas serum 25OHD fell rapidly in the D2-treated subjects and was not different from baseline at 14 d. Area under the curve (AUC) to d 28 was 60.2 ng·d/ml (150.5 nmol·d/liter) for vitamin D2 and 204.7 (511.8) for vitamin D3 (P <0.002). Calculated AUC∞ indicated an even greater differential, with the relative potencies for D 3:D2 being 9.5:1. Vitamin D2 potency is less than one third that of vitamin D3. Physicians resorting to use of vitamin D2 should be aware of its markedly lower potency and shorter duration of action relative to vitamin D3.

AB - Vitamins D2 and D3 are generally considered to be equivalent in humans. Nevertheless, physicians commonly report equivocal responses to seemingly large doses of the only high-dose calciferol (vitamin D2) available in the U.S. market. The relative potencies of vitamins D2 and D3 were evaluated by administering single doses of 50,000 IU of the respective calciferols to 20 healthy male volunteers, following the time course of serum vitamin D and 25-hydroxyvitamin D (25OHD) over a period of 28 d and measuring the area under the curve of the rise in 25OHD above baseline. The two calciferols produced similar rises in serum concentration of the administered vitamin, indicating equivalent absorption. Both produced similar initial rises in serum 25OHD over the first 3 d, but 25OHD continued to rise in the D3-treated subjects, peaking at 14 d, whereas serum 25OHD fell rapidly in the D2-treated subjects and was not different from baseline at 14 d. Area under the curve (AUC) to d 28 was 60.2 ng·d/ml (150.5 nmol·d/liter) for vitamin D2 and 204.7 (511.8) for vitamin D3 (P <0.002). Calculated AUC∞ indicated an even greater differential, with the relative potencies for D 3:D2 being 9.5:1. Vitamin D2 potency is less than one third that of vitamin D3. Physicians resorting to use of vitamin D2 should be aware of its markedly lower potency and shorter duration of action relative to vitamin D3.

UR - http://www.scopus.com/inward/record.url?scp=8744276604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8744276604&partnerID=8YFLogxK

U2 - 10.1210/jc.2004-0360

DO - 10.1210/jc.2004-0360

M3 - Article

C2 - 15531486

AN - SCOPUS:8744276604

VL - 89

SP - 5387

EP - 5391

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -